Adaptin Bio (APTN) Interest Expenses (2022 - 2026)

Adaptin Bio (APTN) has 5 years of Interest Expenses data on file, last reported at $1943.0 in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 97.33% year-over-year to $1943.0; the trailing twelve-month figure through Mar 2026 stood at $65018.0 (down 82.62% YoY), and the FY2025 full-year result was $2.0 million, up 152.71% from the prior year.
• Interest Expenses fell to $1943.0 in Q1 2026, from $63075.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $145887.0 in Q4 2024 to a low of $1943.0 in Q1 2026.
• A 5-year average of $57777.0 and a median of $49045.0 in 2024 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses jumped 506.89% in 2023 and sank 97.33% in 2026, its largest moves.
• Tracing APTN's Interest Expenses over 5 years: stood at $5838.0 in 2022, then jumped by 506.89% to $35430.0 in 2023, then surged by 311.76% to $145887.0 in 2024, then sank by 56.76% to $63075.0 in 2025, then tumbled by 96.92% to $1943.0 in 2026.
• Business Quant data shows APTN's Interest Expenses at $1943.0 in Q1 2026, $63075.0 in Q4 2025, and $72659.0 in Q1 2025.